GPM Logo.jpg
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Oasmia Pharmaceutical AB
September 23, 2019 11:00 ET | Glancy Prongay & Murray LLP
LOS ANGELES, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 27, 2019 deadline to file a lead plaintiff motion in the class...
Schall Firm Logo 2.jpg
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 20, 2019 11:05 ET | Schall Law
LOS ANGELES, Sept. 20, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB...
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Oasmia Pharmaceutical AB
September 20, 2019 11:00 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Sept. 20, 2019 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors of the upcoming September 27, 2019 deadline to file a lead plaintiff motion in the class action...
Schall Firm Logo 2.jpg
UPCOMING DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 16, 2019 09:15 ET | Schall Law
LOS ANGELES, Sept. 16, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB...
HAGENS-BERMAN-securities-press-release.jpg
OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline
September 10, 2019 20:08 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 lead plaintiff deadline in a federal securities...
Schall Firm Logo 2.jpg
UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 09, 2019 10:30 ET | Schall Law
LOS ANGELES, Sept. 09, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB...
HB Press Release Logo.jpg
OASM LITIGATION DEADLINE REMINDER: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of September 27, 2019 Lead Plaintiff Deadline
September 03, 2019 20:11 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 lead plaintiff deadline in a federal securities...
Schall Firm Logo 2.jpg
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
September 03, 2019 09:15 ET | Schall Law
LOS ANGELES, Sept. 03, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB...
HB Press Release Logo.jpg
OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline
August 28, 2019 20:07 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Hagens Berman reminds investors in Oasmia Pharmaceutical AB (NASDAQ: OASM) of the September 27, 2019 lead plaintiff deadline in a federal securities...
Schall Firm Logo 2.jpg
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
August 26, 2019 12:21 ET | Schall Law
LOS ANGELES, Aug. 26, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB...